SBI Securities’s CalciMedica CALC Stock Holding History

SBI Securities’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$90	Hold	17	–	–	﹤0.01%	3531
2026 Q1	$47	Sell	17 -1	-6%	-$10	﹤0.01%	3586
2025 Q4	$593	Sell	18 -6	-25%	-$117	﹤0.01%	2807
2025 Q3	$375	Hold	24	–	–	﹤0.01%	3093
2025 Q2	$194	Hold	24	–	–	﹤0.01%	3317
2025 Q1	$231	Hold	24	–	–	﹤0.01%	3170
2024 Q4	$428	Buy	+24	New	+$421	﹤0.01%	2951

Other funds holding CALC

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

SCM

Squadron Capital Management Westmont, Illinois $322M AUM

Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

LGM

L1 Global Manager Melbourne $142M AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SBI Securities's CALC Position: Q2 2026 in Review

SBI Securities held its CalciMedica (CALC) position steady in Q2 2026 at 17 shares worth $90. The position accounts for ﹤0.01% of the portfolio, ranked #3531.

SBI Securities first reported a position in CALC in Q4 2024 and has held it in 7 quarters since. The position peaked at $593 in Q4 2025. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

SBI Securities held 17 shares of CalciMedica worth $90 as of Q2 2026.
SBI Securities left its CalciMedica share count unchanged in Q2 2026.
CalciMedica made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3531 holding.
SBI Securities first reported a position in CalciMedica in Q4 2024 and has held it in 7 quarters since.
SBI Securities's CalciMedica position peaked at $593 in Q4 2025.
31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.